BrainJuicers Sell Shares as Investors Pile In

BrainJuicer CEO John Kearon has sold 700,000 company shares and CFO James Geddes 75,000, in response to 'institutional demand' from investors wanting to take a stake in the company.

The pair offloaded their shares for around 250p each, giving Kearon £1.75m and Geddes £187,500. Kearon continues to hold 4.5 million shares (36.22% of the company), a stake currently worth more than £11m, while Geddes retains 173,325 shares (1.39% of the company), worth around £433k.

Last month, early investor Unilever sold its remaining 13.5% stake in BrainJuicer, offloading c1.68m company shares for £2.35 each, and raising around £3.9m in the process.

The firm announced this morning that three investors - Sleep, Zakaria & Company, Herald Investment Management, and Standard Life - have each recently acquired 700,000 Brainjuicer shares, giving them each 5.62% of the company.

Web site: www.brainjuicer.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• BrainJuicer
• All news